The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages
Open accessAbstract
Summary: Clear Cell Renal Carcinoma (ccRCC) is a heterogeneous disease with a variable post-surgical course. To assemble a comprehensive ccRCC tumor microenvironment (TME) atlas, we performed single-cell RNA sequencing (scRNASeq) of hematopoietic and non-hematopoietic subpopulations from tumor and tumor-adjacent tissue of treatment-naïve ccRCC resections. We leveraged the VIPER algorithm to quantitate single-cell protein activity, and validated this approach by comparison to flow cytometry. The analysis identified key TME sub-populations, as well as their master regulators and candidate cell-cell interactions, revealing clinically-relevant populations, undetectable by gene expression analysis. Specifically, we uncovered a tumor-specific macrophage subpopulation characterized by upregulation of TREM2/APOE/C1Q - validated by spatially-resolved, quantitative multispectral immunofluorescence. In a large clinical validation cohort, these markers were significantly enriched in tumors from patients who recurred following surgery. The study thus identifies TREM2/APOE/C1Q-positive macrophage infiltration as a potential prognostic biomarker for ccRCC recurrence, as well as a candidate therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Aran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0276-y · Cited by 4,984
Finak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., Slichter, C. K., Miller, H. W., McElrath, M. J., Prlic, M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0844-5 · Cited by 3,159
Simultaneous epitope and transcriptome measurement in single cells
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P. K., Swerdlow, H., Satija, R., & Smibert, P. (2017) · Nature Methods · doi:10.1038/nmeth.4380 · Cited by 3,098
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241
Self-citationDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., et al. (2019) · Nature · doi:10.1038/s41586-019-1325-x · Cited by 1,646
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.006 · Cited by 1,429
Reverse engineering of regulatory networks in human B cells
Basso, K., Margolin, A. A., Stolovitzky, G., Klein, U., Dalla-Favera, R., & Califano, A. (2005) · Nature Genetics · doi:10.1038/ng1532 · Cited by 1,404
Self-citationCD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Barkal, A. A., Brewer, R. E., Markovic, M., Kowarsky, M., Barkal, S. A., Zaro, B. W., Krishnan, V., Hatakeyama, J., Dorigo, O., Barkal, L. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1456-0 · Cited by 1,385
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384
Davoli, T., Uno, H., Wooten, E. C., & Elledge, S. J. (2017) · Science · doi:10.1126/science.aaf8399 · Cited by 1,360
The transcriptional network for mesenchymal transformation of brain tumours
Carro, M. S., Lim, W. K., Alvarez, M. J., Bollo, R. J., Zhao, X., Snyder, E. Y., Sulman, E. P., Anne, S. L., Doetsch, F., Colman, H., et al. (2010) · Nature · doi:10.1038/nature08712 · Cited by 1,259
Self-citationTOX is a critical regulator of tumour-specific T cell differentiation
Scott, A. C., Dündar, F., Zumbo, P., Chandran, S. S., Klebanoff, C. A., Shakiba, M., Trivedi, P., Menocal, L., Appleby, H., Camara, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1324-y · Cited by 1,106
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Chevrier, S., Levine, J. H., Zanotelli, V. R. T., Silina, K., Schulz, D., Bacac, M., Ries, C. H., Ailles, L., Jewett, M. A. S., Moch, H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.016 · Cited by 1,004
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15081 · Cited by 992
Şenbabaoğlu, Y., Gejman, R. S., Winer, A. G., Liu, M., Van Allen, E. M., de Velasco, G., Miao, D., Ostrovnaya, I., Drill, E., Luna, A., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1092-z · Cited by 968
Alvarez, M. J., Shen, Y., Giorgi, F. M., Lachmann, A., Ding, B. B., Ye, B. H., & Califano, A. (2016) · Nature Genetics · doi:10.1038/ng.3593 · Cited by 966
Self-citationTurajlic, S., Litchfield, K., Xu, H., Rosenthal, R., McGranahan, N., Reading, J. L., Wong, Y. N. S., Rowan, A., Kanu, N., Al Bakir, M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30516-8 · Cited by 911
Tertiary lymphoid structures in cancer and beyond
Dieu-Nosjean, M.-C., Goc, J., Giraldo, N. A., Sautès-Fridman, C., & Fridman, W. H. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.09.006 · Cited by 617
Giraldo, N. A., Becht, E., Pagès, F., Skliris, G., Verkarre, V., Vano, Y., Mejean, A., Saint-Aubert, N., Lacroix, L., Natario, I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2926 · Cited by 507
Katzenelenbogen, Y., Sheban, F., Yalin, A., Yofe, I., Svetlichnyy, D., Jaitin, D. A., Bornstein, C., Moshe, A., Keren-Shaul, H., Cohen, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.032 · Cited by 498
Arce Vargas, F., Furness, A. J. S., Solomon, I., Joshi, K., Mekkaoui, L., Lesko, M. H., Miranda Rota, E., Dahan, R., Georgiou, A., Sledzinska, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.013 · Cited by 418
Lachmann, A., Giorgi, F. M., Lopez, G., & Califano, A. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw216 · Cited by 407
Self-citationGiraldo, N. A., Becht, E., Vano, Y., Petitprez, F., Lacroix, L., Validire, P., Sanchez-Salas, R., Ingels, A., Oudard, S., Moatti, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2848 · Cited by 375
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
Finke, J., Ko, J., Rini, B., Rayman, P., Ireland, J., & Cohen, P. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.030 · Cited by 281
Self-citationFu, Q., Chen, N., Ge, C., Li, R., Li, Z., Zeng, B., Li, C., Wang, Y., Xue, Y., Song, X., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1593806 · Cited by 274
Update of the FANTOM web resource: expansion to provide additional transcriptome atlases
Lizio, M., Abugessaisa, I., Noguchi, S., Kondo, A., Hasegawa, A., Hon, C. C., de Hoon, M., Severin, J., Oki, S., Hayashizaki, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1099 · Cited by 272
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth
Roumenina, L. T., Daugan, M. V., Noé, R., Petitprez, F., Vano, Y. A., Sanchez-Salas, R., Becht, E., Meilleroux, J., Clec'h, B. L., Giraldo, N. A., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0891 · Cited by 269
BLUEPRINT: mapping human blood cell epigenomes
Martens, J. H. A., & Stunnenberg, H. G. (2013) · Haematologica · doi:10.3324/haematol.2013.094243 · Cited by 267
Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
Maus, M. V., & June, C. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1433 · Cited by 265
Granier, C., Dariane, C., Combe, P., Verkarre, V., Urien, S., Badoual, C., Roussel, H., Mandavit, M., Ravel, P., Sibony, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0274 · Cited by 213
Alvarez, M. J., Subramaniam, P. S., Tang, L. H., Grunn, A., Aburi, M., Rieckhof, G., Komissarova, E. V., Hagan, E. A., Bodei, L., Clemons, P. A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0138-4 · Cited by 210
Self-citationCD70: An emerging target in cancer immunotherapy
Jacobs, J., Deschoolmeester, V., Zwaenepoel, K., Rolfo, C., Silence, K., Rottey, S., Lardon, F., Smits, E., & Pauwels, P. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.007 · Cited by 206
Mani, K. M., Lefebvre, C., Wang, K., Lim, W. K., Basso, K., Dalla‐Favera, R., & Califano, A. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.2 · Cited by 205
Self-citationGao, G., Wang, Z., Qu, X., & Zhang, Z. (2020) · BMC Cancer · doi:10.1186/s12885-020-6668-z · Cited by 205
Najjar, Y. G., Rayman, P., Jia, X., Pavicic, P. G., Rini, B. I., Tannenbaum, C., Ko, J., Haywood, S., Cohen, P., Hamilton, T., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1823 · Cited by 194
Self-citationHsieh, J. J., Le, V. H., Oyama, T., Ricketts, C. J., Ho, T. H., & Cheng, E. H. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2549 · Cited by 182
MacFarlane, A. W., Jillab, M., Plimack, E. R., Hudes, G. R., Uzzo, R. G., Litwin, S., Dulaimi, E., Al-Saleem, T., & Campbell, K. S. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0133 · Cited by 177
Systemic treatment of renal cell cancer: A comprehensive review
Sánchez-Gastaldo, A., Kempf, E., González del Alba, A., & Duran, I. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.08.010 · Cited by 175
Molecular aspects of renal cell carcinoma: a review.
Koul, H. K., Huh, J., Rove, K. O., Crompton, L., Koul, S., Meacham, R. B., & Kim, F. J. (2011) · Europe PMC (PubMed Central) · Cited by 136
Ding, H., Douglass, E. F., Sonabend, A. M., Mela, A., Bose, S., Gonzalez, C., Canoll, P., Sims, P. A., Alvarez, M. J., & Califano, A. (2018) · Nature Communications · doi:10.1038/s41467-018-03843-3 · Cited by 122
Self-citationRenal cell carcinoma: the search for a reliable biomarker
Farber, N. J., Kim, C. J., Modi, P. K., Hon, J. D., Sadimin, E. T., & Singer, E. A. (2017) · Translational Cancer Research · doi:10.21037/tcr.2017.05.19 · Cited by 119
Roussos, P., Katsel, P., Fam, P., Tan, W., Purohit, D. P., & Haroutunian, V. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.013 · Cited by 103
Dutta, A., Magnen, C. L., Mitrofanova, A., Ouyang, X., Califano, A., & Abate-Shen, C. T. (2016) · Science · doi:10.1126/science.aad9512 · Cited by 98
Self-citationThe Immunobiology of Kidney Cancer
Drake, C. G., & Stein, M. N. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2648 · Cited by 93
Self-citationZeleke, T. Z., Pan, Q., Chiuzan, C. C., Onishi, M., Li, Y., Tan, H., Alvarez, M. J., Honan, E., Yang, M., Chia, P. L., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00489-5 · Cited by 90
Self-citationCD70 expression patterns in renal cell carcinoma
Jilaveanu, L. B., Sznol, J. A., Aziz, S. A., Duchen, D., Kluger, H. M., & Camp, R. L. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.10.014 · Cited by 89
Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
Li, X., Ma, X., Chen, L., Gu, L., Zhang, Y., Zhang, F., Ouyang, Y., Gao, Y., Huang, Q., & Zhang, X. (2015) · Scientific Reports · doi:10.1038/srep13157 · Cited by 73
Wang, X., Tao, B., Li, B., Wang, X., Zhang, W., Wan, L., Hua, X., & Li, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6221 · Cited by 71
Unlocking the Complexities of Tumor-Associated Regulatory T Cells
Chao, J. L., & Savage, P. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701188 · Cited by 69
Becht, É., Giraldo, N. A., Beuselinck, B., Job, S., Marisa, L., Vano, Y. A., Oudard, S. M., Zucman‐Rossi, J., Laurent‐Puig, P., Sautès‐Fridman, C., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1049804 · Cited by 68
A phase 1 trial of SGN‐CD70A in patients with CD70‐positive, metastatic renal cell carcinoma
Pal, S. K., Forero, A., Thompson, J. A., Morris, J. C., Chhabra, S., Hoimes, C. J., Vogelzang, N. J., Boyd, T. E., Bergerot, P. G., Adashek, J. J., et al. (2019) · Cancer · doi:10.1002/cncr.31912 · Cited by 66
Yao, Y., Li, H., Chen, J., Xu, W., Yang, G., Bao, Z., Xia, D., Lu, G., Hu, S., & Zhou, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8813 · Cited by 57
El‐Mokadem, I., Fitzpatrick, P., Bondad, J., Rauchhaus, P., Cunningham, J., Pratt, N., Fleming, S., & Nabi, G. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.420 · Cited by 44
Arumugam, K., Shin, W., Schiavone, V., Vlahos, L. J., Tu, X., Carnevali, D., Kesner, J. S., Paull, E., Romo, N., Subramaniam, P. S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108474 · Cited by 34
Self-citationTalos, F., Mitrofanova, A., Bergren, S. K., Califano, A., & Shen, M. M. (2017) · Nature Communications · doi:10.1038/ncomms14662 · Cited by 33
Self-citationPrognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma
Arık, D., Can, C., Dündar, E., Kabukçuoğlu, S., & Paşaoğlu, Ö. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0128-8 · Cited by 27
Zeleke, T. Z., Pan, Q., Chiuzan, C. C., Onishi, M., Alvarez, M. J., Honan, E., Yang, M., Chia, P. L., Mukhopadhyay, P., Kelly, S. C., et al. (2020) · SSRN Electronic Journal · doi:10.1101/2020.04.23.20066928 · Cited by 8
Self-citationRamı́rez, A., Karsak, M., Thelen, M., Glebov, K., Nagler, M., Rading, S., Thiele, H., Lernnarz, M., Jessen, F., Maier, W., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.585 · Cited by 4
Cited by
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Colonna, M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00837-1 · Cited by 394
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Zhang, H., Liu, L., Liu, J., Dang, P., Hu, S., Yuan, W., Sun, Z., Liu, Y., & Wang, C. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01725-x · Cited by 389
Targeting TREM2 on tumor-associated macrophages enhances immunotherapy
Binnewies, M., Pollack, J. L., Rudolph, J., Dash, S., Abushawish, M., Lee, T., Jahchan, N. S., Canaday, P., Lu, E., Norng, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109844 · Cited by 365
Single-cell proteomics enabled by next-generation sequencing or mass spectrometry
Bennett, H. M., Stephenson, W., Rose, C. M., & Darmanis, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01791-5 · Cited by 351
Metadata
- Authors
- Obradovic, A., Chowdhury, N., Haake, S. M., Ager, C., Wang, V., Vlahos, L., Guo, X. V., Aggen, D. H., Rathmell, W. K., Jonasch, E., Johnson, J. E., Roth, M., Beckermann, K. E., Rini, B. I., McKiernan, J., Califano, A., & Drake, C. G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 184
- Issue
- 11
- Pages
- 2988-3005.e16
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3160973971
- Cited by
- 349
- References
- 65
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.